Julia Ding, PhDHead, Global Process Analytics at Bristol Myers Squibb
Julia Ding is leading a global process analytics team at Bristol Myers Squibb Biologic Development. She is leading a diverse and cross-functional team responsible for:
- Establishing strategic vision and implementation of global biologic PAT and rapid analysis technology advancement
- Establishing and advancing new technologies in PAT and real-time release of biologic process
- Advancing and implementing high throughput analytical methodologies to enable and support bioprocess development and characterization.
- Advancing phase appropriate analytical CMC control strategies throughout biologic clinical development phases
Julia Ding had been serving as a chair of BMS biologic specification committee and a core member in biologic comparability council.
Prior to joining Bristol Myers Squibb, Julia Ding led a multifunctional analytical development team responsible for analytical assay development/validation/life cycle management, characterization and cGMP quality control testing of biologic products at PPD. Julia obtained her Ph.D. in physical organic chemistry from Emory University and postdoc from University of California at Berkeley.